Abstract
It is generally accepted that morphine acts presynaptically to inhibit substance P (SP) release from afferent terminals in the trigeminal nucleus. Recent studies, however, provide evidence that opioids produce both inhibitory and excitatory effects on SP release which are concentration- and receptor subtype-dependent. In the present study, we have examined a wide range of morphine concentrations on K+ -evoked SP release from rat trigeminal nucleus caudalis slices. Immunoreactive SP was measured in perfusates. Morphine produces multiphasic effects on K+-evoked SP release without affecting basal release. A very low nannomolar concentration (1 nM) suppressed release, higher nanomolar concentrations (100-300 nM) facilitated release, a low micromolar concentration (3 μM) suppressed release, and a higher micromolar concentration (30 μM) facilitated release. These effects were abolished by opioid receptor blockade with naloxone (30 nM). Thus, morphine produces a complex bi-directional modulation of SP release from TNC which is concentration- and possibly receptor subtype-dependent.
Original language | English (US) |
---|---|
Pages (from-to) | 187-194 |
Number of pages | 8 |
Journal | Brain Research |
Volume | 579 |
Issue number | 2 |
DOIs | |
State | Published - May 8 1992 |
Keywords
- Morphine
- Naloxone
- Opioid receptor
- Peptide release
- Substance P
- Trigeminal nucleus caudalis
ASJC Scopus subject areas
- Neuroscience(all)
- Molecular Biology
- Clinical Neurology
- Developmental Biology